table of content
1 Introduction to Research & Analysis Reports
1.1 RNA Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA Drugs Overall Market Size
2.1 Global RNA Drugs Market Size: 2022 VS 2029
2.2 Global RNA Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global RNA Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top RNA Drugs Players in Global Market
3.2 Top Global RNA Drugs Companies Ranked by Revenue
3.3 Global RNA Drugs Revenue by Companies
3.4 Global RNA Drugs Sales by Companies
3.5 Global RNA Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 RNA Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers RNA Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 RNA Drugs Players in Global Market
3.8.1 List of Global Tier 1 RNA Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 RNA Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global RNA Drugs Market Size Markets, 2022 & 2029
4.1.2 siRNA
4.1.3 ASO
4.1.4 miRNA
4.1.5 Nucleic Acid Aptamers
4.2 By Type - Global RNA Drugs Revenue & Forecasts
4.2.1 By Type - Global RNA Drugs Revenue, 2018-2023
4.2.2 By Type - Global RNA Drugs Revenue, 2024-2029
4.2.3 By Type - Global RNA Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global RNA Drugs Sales & Forecasts
4.3.1 By Type - Global RNA Drugs Sales, 2018-2023
4.3.2 By Type - Global RNA Drugs Sales, 2024-2029
4.3.3 By Type - Global RNA Drugs Sales Market Share, 2018-2029
4.4 By Type - Global RNA Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA Drugs Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Diabetes
5.1.4 Tuberculosis
5.1.5 Cardiovascular Diseases
5.1.6 Others
5.2 By Application - Global RNA Drugs Revenue & Forecasts
5.2.1 By Application - Global RNA Drugs Revenue, 2018-2023
5.2.2 By Application - Global RNA Drugs Revenue, 2024-2029
5.2.3 By Application - Global RNA Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global RNA Drugs Sales & Forecasts
5.3.1 By Application - Global RNA Drugs Sales, 2018-2023
5.3.2 By Application - Global RNA Drugs Sales, 2024-2029
5.3.3 By Application - Global RNA Drugs Sales Market Share, 2018-2029
5.4 By Application - Global RNA Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global RNA Drugs Market Size, 2022 & 2029
6.2 By Region - Global RNA Drugs Revenue & Forecasts
6.2.1 By Region - Global RNA Drugs Revenue, 2018-2023
6.2.2 By Region - Global RNA Drugs Revenue, 2024-2029
6.2.3 By Region - Global RNA Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global RNA Drugs Sales & Forecasts
6.3.1 By Region - Global RNA Drugs Sales, 2018-2023
6.3.2 By Region - Global RNA Drugs Sales, 2024-2029
6.3.3 By Region - Global RNA Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America RNA Drugs Revenue, 2018-2029
6.4.2 By Country - North America RNA Drugs Sales, 2018-2029
6.4.3 US RNA Drugs Market Size, 2018-2029
6.4.4 Canada RNA Drugs Market Size, 2018-2029
6.4.5 Mexico RNA Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe RNA Drugs Revenue, 2018-2029
6.5.2 By Country - Europe RNA Drugs Sales, 2018-2029
6.5.3 Germany RNA Drugs Market Size, 2018-2029
6.5.4 France RNA Drugs Market Size, 2018-2029
6.5.5 U.K. RNA Drugs Market Size, 2018-2029
6.5.6 Italy RNA Drugs Market Size, 2018-2029
6.5.7 Russia RNA Drugs Market Size, 2018-2029
6.5.8 Nordic Countries RNA Drugs Market Size, 2018-2029
6.5.9 Benelux RNA Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia RNA Drugs Revenue, 2018-2029
6.6.2 By Region - Asia RNA Drugs Sales, 2018-2029
6.6.3 China RNA Drugs Market Size, 2018-2029
6.6.4 Japan RNA Drugs Market Size, 2018-2029
6.6.5 South Korea RNA Drugs Market Size, 2018-2029
6.6.6 Southeast Asia RNA Drugs Market Size, 2018-2029
6.6.7 India RNA Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America RNA Drugs Revenue, 2018-2029
6.7.2 By Country - South America RNA Drugs Sales, 2018-2029
6.7.3 Brazil RNA Drugs Market Size, 2018-2029
6.7.4 Argentina RNA Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa RNA Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa RNA Drugs Sales, 2018-2029
6.8.3 Turkey RNA Drugs Market Size, 2018-2029
6.8.4 Israel RNA Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia RNA Drugs Market Size, 2018-2029
6.8.6 UAE RNA Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer RNA Drugs Major Product Offerings
7.1.4 Pfizer RNA Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche RNA Drugs Major Product Offerings
7.2.4 Roche RNA Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Company Summary
7.3.2 Sanofi-Aventis Business Overview
7.3.3 Sanofi-Aventis RNA Drugs Major Product Offerings
7.3.4 Sanofi-Aventis RNA Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi-Aventis Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories RNA Drugs Major Product Offerings
7.4.4 Abbott Laboratories RNA Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Arrowhead Pharmaceuticals
7.5.1 Arrowhead Pharmaceuticals Company Summary
7.5.2 Arrowhead Pharmaceuticals Business Overview
7.5.3 Arrowhead Pharmaceuticals RNA Drugs Major Product Offerings
7.5.4 Arrowhead Pharmaceuticals RNA Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Arrowhead Pharmaceuticals Key News & Latest Developments
7.6 Benitec Biopharma
7.6.1 Benitec Biopharma Company Summary
7.6.2 Benitec Biopharma Business Overview
7.6.3 Benitec Biopharma RNA Drugs Major Product Offerings
7.6.4 Benitec Biopharma RNA Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Benitec Biopharma Key News & Latest Developments
7.7 Calimmune Inc
7.7.1 Calimmune Inc Company Summary
7.7.2 Calimmune Inc Business Overview
7.7.3 Calimmune Inc RNA Drugs Major Product Offerings
7.7.4 Calimmune Inc RNA Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Calimmune Inc Key News & Latest Developments
7.8 Dicerna
7.8.1 Dicerna Company Summary
7.8.2 Dicerna Business Overview
7.8.3 Dicerna RNA Drugs Major Product Offerings
7.8.4 Dicerna RNA Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Dicerna Key News & Latest Developments
7.9 Gradalis
7.9.1 Gradalis Company Summary
7.9.2 Gradalis Business Overview
7.9.3 Gradalis RNA Drugs Major Product Offerings
7.9.4 Gradalis RNA Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Gradalis Key News & Latest Developments
7.10 Quark
7.10.1 Quark Company Summary
7.10.2 Quark Business Overview
7.10.3 Quark RNA Drugs Major Product Offerings
7.10.4 Quark RNA Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Quark Key News & Latest Developments
7.11 RXi
7.11.1 RXi Company Summary
7.11.2 RXi RNA Drugs Business Overview
7.11.3 RXi RNA Drugs Major Product Offerings
7.11.4 RXi RNA Drugs Sales and Revenue in Global (2018-2023)
7.11.5 RXi Key News & Latest Developments
7.12 Senesco
7.12.1 Senesco Company Summary
7.12.2 Senesco RNA Drugs Business Overview
7.12.3 Senesco RNA Drugs Major Product Offerings
7.12.4 Senesco RNA Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Senesco Key News & Latest Developments
7.13 Silence Therapeutics
7.13.1 Silence Therapeutics Company Summary
7.13.2 Silence Therapeutics RNA Drugs Business Overview
7.13.3 Silence Therapeutics RNA Drugs Major Product Offerings
7.13.4 Silence Therapeutics RNA Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Silence Therapeutics Key News & Latest Developments
7.14 Silenseed
7.14.1 Silenseed Company Summary
7.14.2 Silenseed Business Overview
7.14.3 Silenseed RNA Drugs Major Product Offerings
7.14.4 Silenseed RNA Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Silenseed Key News & Latest Developments
7.15 Tekmira
7.15.1 Tekmira Company Summary
7.15.2 Tekmira Business Overview
7.15.3 Tekmira RNA Drugs Major Product Offerings
7.15.4 Tekmira RNA Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Tekmira Key News & Latest Developments
7.16 Alnylam Pharmaceuticals
7.16.1 Alnylam Pharmaceuticals Company Summary
7.16.2 Alnylam Pharmaceuticals Business Overview
7.16.3 Alnylam Pharmaceuticals RNA Drugs Major Product Offerings
7.16.4 Alnylam Pharmaceuticals RNA Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Alnylam Pharmaceuticals Key News & Latest Developments
8 Global RNA Drugs Production Capacity, Analysis
8.1 Global RNA Drugs Production Capacity, 2018-2029
8.2 RNA Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global RNA Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RNA Drugs Supply Chain Analysis
10.1 RNA Drugs Industry Value Chain
10.2 RNA Drugs Upstream Market
10.3 RNA Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 RNA Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
